Sustained virological response of pegylated interferon α-2A plus ribavirin in patients with chronic hepatitis C genotype 4

被引：0
|
作者：
Shiha, G
Gabre, M
Zalata, K
Sayed, S
机构：
[1] Mansoura Univ, Fac Med, Dept Internal Med, Mansoura, Egypt
[2] Mansoura Univ, Dept Pathol, Mansoura, Egypt
[3] Tanta Univ, Fac Med, Dept Internal Med, Tanta, Egypt
来源：
GUT | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
316
引用
收藏
页码：A81 / A81
页数：1
相关论文
共 50 条
  • [21] IMPACT OF ETHNICITY ON VIRAL KINETICS AND SUSTAINED VIROLOGICAL RESPONSE RATES OF GENOTYPE 4, CHRONIC HEPATITIS C PATIENTS TREATED WITH PEG-INTERFERON-A2A PLUS RIBAVIRIN
    Elefsiniotis, L.
    Pavlidis, C.
    Dimitropoulos, D.
    Mihas, C.
    Vezali, E.
    Koutsounas, S.
    Paraskevas, E.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S224 - S225
  • [22] IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C
    Estrabaud, Emilie
    Appourchaux, Kevin
    Bieche, Ivan
    Carrat, Fabrice
    Lapalus, Martine
    Lada, Olivier
    Martinot-Peignoux, Michelle
    Boyer, Nathalie
    Marcellin, Patrick
    Vidaud, Michel
    Asselah, Tarik
    PLOS ONE, 2015, 10 (04):
  • [23] Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan
    Kogure, Takayuki
    Ueno, Yoshiyuki
    Fukushima, Koji
    Nagasaki, Futoshi
    Kondo, Yasuteru
    Inoue, Jun
    Matsuda, Yasunori
    Kakazu, Eiji
    Yamamoto, Takeshi
    Onodera, Hiroyoshi
    Miyazaki, Yutaka
    Okamoto, Hiromasa
    Akahane, Takehiro
    Kobayashi, Tomoo
    Mano, Yutaka
    Iwasaki, Takao
    Ishii, Motoyasu
    Shimosegawa, Tooru
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (47) : 7225 - 7230
  • [24] Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV
    Medrano, Jose
    Neukam, Karin
    Rallon, Norma
    Rivero, Antonio
    Resino, Salvador
    Naggie, Susanna
    Caruz, Antonio
    Calvino, Aida
    Macias, Juan
    Miguel Benito, Jose
    Sanchez-Piedra, Carlos
    Vispo, Eugenia
    Barreiro, Pablo
    McHutchison, John
    Antonio Pineda, Juan
    Soriano, Vincent
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (10) : 1209 - 1216
  • [25] Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin
    Perrella, A.
    Sbreglia, C.
    Atripaldi, L.
    Esposito, C.
    D'Antonio, A.
    Perrella, O.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (02) : 250 - 255
  • [26] Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan
    Takayuki Kogure
    Yoshiyuki Ueno
    Koji Fukushima
    Futoshi Nagasaki
    Yasuteru Kondo
    Jun Inoue
    Yasunori Matsuda
    Eiji Kakazu
    Takeshi Yamamoto
    Hiroyoshi Onodera
    Yutaka Miyazaki
    Hiromasa Okamoto
    Takehiro Akahane
    Tomoo Kobayashi
    Yutaka Mano
    Takao Iwasaki
    Motoyasu Ishii
    Tooru Shimosegawa
    World Journal of Gastroenterology, 2008, 14 (47) : 7225 - 7230
  • [27] Serum proteome profile to predict virological response in patients with chronic hepatitis C treated by pegylated interferon plus ribavirin
    Paradis, V
    Asselah, T
    Dargere, D
    Ripault, MP
    Martinot, M
    Boyer, N
    Valla, D
    Marcellin, P
    Bedossa, P
    HEPATOLOGY, 2005, 42 (04) : 444A - 444A
  • [28] Immunological biomarkers of virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Menezes, E.
    Reis, J.
    Cardoso, L.
    Teixeira Carvalho, A.
    Filho, A. M. O.
    Teixeira, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1269 - 1269
  • [29] Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon α-2a and ribavirin
    Yu, Jian-Wu
    Wang, Gui-Qiang
    Sun, Li-Jie
    Li, Xiao-Guang
    Li, Shu-Chen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) : 832 - 836
  • [30] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
12345